237 related articles for article (PubMed ID: 27452957)
1. Antifungal potential of eugenyl acetate against clinical isolates of Candida species.
Musthafa KS; Hmoteh J; Thamjarungwong B; Voravuthikunchai SP
Microb Pathog; 2016 Oct; 99():19-29. PubMed ID: 27452957
[TBL] [Abstract][Full Text] [Related]
2. Characterising the post-antifungal effects of micafungin against Candida albicans, Candida glabrata, Candida parapsilosis and Candida krusei isolates.
Nguyen KT; Ta P; Hoang BT; Cheng S; Hao B; Nguyen MH; Clancy CJ
Int J Antimicrob Agents; 2010 Jan; 35(1):80-4. PubMed ID: 19889519
[TBL] [Abstract][Full Text] [Related]
3. Comparative Study of the Effects of Fluconazole and Voriconazole on Candida glabrata, Candida parapsilosis and Candida rugosa Biofilms.
Madhavan P; Jamal F; Pei CP; Othman F; Karunanidhi A; Ng KP
Mycopathologia; 2018 Jun; 183(3):499-511. PubMed ID: 29380188
[TBL] [Abstract][Full Text] [Related]
4. Antifungal activity, mode of action and anti-biofilm effects of Laurus nobilis Linnaeus essential oil against Candida spp.
Peixoto LR; Rosalen PL; Ferreira GL; Freires IA; de Carvalho FG; Castellano LR; de Castro RD
Arch Oral Biol; 2017 Jan; 73():179-185. PubMed ID: 27771586
[TBL] [Abstract][Full Text] [Related]
5. Candida and candidaemia. Susceptibility and epidemiology.
Arendrup MC
Dan Med J; 2013 Nov; 60(11):B4698. PubMed ID: 24192246
[TBL] [Abstract][Full Text] [Related]
6. Candida species isolated from different body sites and their antifungal susceptibility pattern: Cross-analysis of Candida albicans and Candida glabrata biofilms.
Cataldi V; Di Campli E; Fazii P; Traini T; Cellini L; Di Giulio M
Med Mycol; 2017 Aug; 55(6):624-634. PubMed ID: 27915303
[TBL] [Abstract][Full Text] [Related]
7. [Molecular epidemiology and antifungal susceptibility of Candida species isolated from urine samples of patients in intensive care unit].
Yüksekkaya S; Fındık D; Arslan U
Mikrobiyol Bul; 2011 Jan; 45(1):137-49. PubMed ID: 21341168
[TBL] [Abstract][Full Text] [Related]
8. Antifungal susceptibilities of Candida glabrata species complex, Candida krusei, Candida parapsilosis species complex and Candida tropicalis causing invasive candidiasis in China: 3 year national surveillance.
Xiao M; Fan X; Chen SC; Wang H; Sun ZY; Liao K; Chen SL; Yan Y; Kang M; Hu ZD; Chu YZ; Hu TS; Ni YX; Zou GL; Kong F; Xu YC
J Antimicrob Chemother; 2015 Mar; 70(3):802-10. PubMed ID: 25473027
[TBL] [Abstract][Full Text] [Related]
9. In vitro activity of eugenol against Candida albicans biofilms.
He M; Du M; Fan M; Bian Z
Mycopathologia; 2007 Mar; 163(3):137-43. PubMed ID: 17356790
[TBL] [Abstract][Full Text] [Related]
10. Liquid and vapour-phase antifungal activities of essential oils against Candida albicans and non-albicans Candida.
Mandras N; Nostro A; Roana J; Scalas D; Banche G; Ghisetti V; Del Re S; Fucale G; Cuffini AM; Tullio V
BMC Complement Altern Med; 2016 Aug; 16(1):330. PubMed ID: 27576581
[TBL] [Abstract][Full Text] [Related]
11. National surveillance of species distribution in blood isolates of Candida species in Japan and their susceptibility to six antifungal agents including voriconazole and micafungin.
Takakura S; Fujihara N; Saito T; Kudo T; Iinuma Y; Ichiyama S
J Antimicrob Chemother; 2004 Feb; 53(2):283-9. PubMed ID: 14688039
[TBL] [Abstract][Full Text] [Related]
12. Association of different Candida species with catheter-related candidemia, and the potential antifungal treatments against their adhesion properties and biofilm-forming capabilities.
Zuo XS; Liu Y; Cai X; Zhan L; Hu K
J Clin Lab Anal; 2021 Apr; 35(4):e23738. PubMed ID: 33608902
[TBL] [Abstract][Full Text] [Related]
13. National surveillance of antifungal susceptibility of Candida species in South Korean hospitals.
Yoo JI; Choi CW; Lee KM; Kim YK; Kim TU; Kim EC; Joo SI; Yun SH; Lee YS; Kim BS
Med Mycol; 2009; 47(5):554-8. PubMed ID: 18819023
[TBL] [Abstract][Full Text] [Related]
14. In vitro antifungal activity of hydroxychavicol isolated from Piper betle L.
Ali I; Khan FG; Suri KA; Gupta BD; Satti NK; Dutt P; Afrin F; Qazi GN; Khan IA
Ann Clin Microbiol Antimicrob; 2010 Feb; 9():7. PubMed ID: 20128889
[TBL] [Abstract][Full Text] [Related]
15. Biofilms of non-Candida albicans Candida species: quantification, structure and matrix composition.
Silva S; Henriques M; Martins A; Oliveira R; Williams D; Azeredo J
Med Mycol; 2009 Nov; 47(7):681-9. PubMed ID: 19888800
[TBL] [Abstract][Full Text] [Related]
16. Miconazole activity against Candida biofilms developed on acrylic discs.
Gebremedhin S; Dorocka-Bobkowska B; Prylinski M; Konopka K; Duzgunes N
J Physiol Pharmacol; 2014 Aug; 65(4):593-600. PubMed ID: 25179092
[TBL] [Abstract][Full Text] [Related]
17. Species distribution and fluconazole susceptibility of Candida clinical isolates in a medical center in 2002.
Wang JL; Chang SC; Hsueh PR; Chen YC
J Microbiol Immunol Infect; 2004 Aug; 37(4):236-41. PubMed ID: 15340652
[TBL] [Abstract][Full Text] [Related]
18. Propolis: a potential natural product to fight Candida species infections.
Tobaldini-Valerio FK; Bonfim-Mendonça PS; Rosseto HC; Bruschi ML; Henriques M; Negri M; Silva S; Svidzinski TIe
Future Microbiol; 2016 Aug; 11():1035-46. PubMed ID: 27501739
[TBL] [Abstract][Full Text] [Related]
19. In vitro synergism between berberine and miconazole against planktonic and biofilm Candida cultures.
Wei GX; Xu X; Wu CD
Arch Oral Biol; 2011 Jun; 56(6):565-72. PubMed ID: 21272859
[TBL] [Abstract][Full Text] [Related]
20. Anti-Candida activity assessment of Pelargonium graveolens oil free and nanoemulsion in biofilm formation in hospital medical supplies.
Giongo JL; de Almeida Vaucher R; Fausto VP; Quatrin PM; Lopes LQS; Santos RCV; Gündel A; Gomes P; Steppe M
Microb Pathog; 2016 Nov; 100():170-178. PubMed ID: 27544324
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
